Vitro Biopharma, Inc. announced that it will receive $3,000,000 in funding on November 16, 2023. The company will issue non-convertible debt and option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
1st Jan change | Capi. | |
---|---|---|
+2.97% | 94.74B | |
-3.68% | 37.28B | |
-12.20% | 32.68B | |
+74.21% | 27.72B | |
-13.96% | 16.19B | |
-2.34% | 13.88B | |
-12.21% | 11.58B | |
+188.83% | 10.92B | |
-53.94% | 9.54B |